Coronary Heart Disease Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes The Lessons From Antagonizing the Cellular Effects of Thrombin–Acute Coronary Syndromes Trial


Michelle L. O’Donoghue, MD, MPH; Deepak L. Bhatt, MD, MPH; Stephen D. Wiviott, MD; Shaun G. Goodman, MD, MSc; Desmond J. Fitzgerald, MD; Dominick J. Angiolillo, MD, PhD; Shinya Goto, MD; Gilles Montalescot, MD, PhD; Uwe Zeymer, MD; Philip E. Aylward, BM, BCh, PhD; Victor Guetta, MD; Dariusz Dudek, MD, PhD; Rafal Ziecina, MD, PhD; Charles F. Contant, PhD… (More)


10 Figures and Tables